Delivery Order SPE2DB20D1100-SPE2DB25FE1HE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,975.64 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,496.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 2, 2025, with a contract value of $1,235.98 and completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,576.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on September 2, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is classified as a child contract...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $29,137.90 delivery order on August 28, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units, with completion scheduled for September 4, 2025. The contract utilizes firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1HEDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,606.25 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities, with performance completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Trulicity, a diabetes medication, exemplifies the type of specialty pharmaceutical products the company routinely delivers through its DLA contracts to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/26/25 |